Open access · CC-BY
via OpenAlex
Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling
Molecular Brain · 2016 · ▲ 75 citations
Abstract
Dementia is a syndrome associated with a wide range of clinical features including progressive cognitive decline and patient inability to self-care. Due to rapidly increasing prevalence in aging society, dementia now confers a major economic, social, and healthcare burden throughout the world, and has therefore been identified as a public health priority by the World Health Organization. Previous studies have established dementia as a 'proteinopathy' caused by detrimental changes in brain protein structure and function that promote misfolding, aggregation, and deposition as insoluble amyloid plaques. Despite clear evidence that pathological cognitive decline is associated with degenerative protein modifications (DPMs) arising from spontaneous chemical modifications to amino acid side chains, the molecular mechanisms that promote brain DPMs formation remain poorly understood. However, the technical challenges associated with DPM analysis have recently become tractable due to powerful new proteomic techniques that facilitate detailed analysis of brain tissue damage over time. Recent studies have identified that neurodegenerative diseases are associated with the dysregulation of critical repair enzymes, as well as the misfolding, aggregation and accumulation of modified brain proteins. Future studies will further elucidate the mechanisms underlying dementia pathogenesis via the quantitative profiling of the human brain proteome and associated DPMs in distinct phases and subtypes of disease. This review summarizes recent developments in quantitative proteomic technologies, describes how these techniques have been applied to the study of dementia-linked changes in brain protein structure and function, and briefly outlines how these findings might be translated into novel clinical applications for dementia patients. In this review, only spontaneous protein modifications such as deamidation, oxidation, nitration glycation and carbamylation are reviewed and discussed.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13041-016-0272-9
- Canonical
- link ↗
- Fetched
- 2026-11-10 MST
Cite this
APA
Adav, S.S., & Sze, S.K. (2016). Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling. <em>Molecular Brain</em>. https://doi.org/10.1186/s13041-016-0272-9
Vancouver
Adav SS, Sze SK. Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling. Molecular Brain. 2016. doi:10.1186/s13041-016-0272-9.
BibTeX
@article{sunil2016Insigh,
title = {Insight of brain degenerative protein modifications in the pathology of neurodegeneration and dementia by proteomic profiling},
author = {Sunil S. Adav and Siu Kwan Sze},
journal = {Molecular Brain},
year = {2016},
doi = {10.1186/s13041-016-0272-9},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
InTech eBooks 2016
Open access · CC-BY
Proteomic Study of Degenerative Protein Modifications in the Molecular Pathology of Neurodegeneration and Dementia
PLoS ONE 2010
Open access · CC-BY
Discovery and Preclinical Validation of Salivary Transcriptomic and Proteomic Biomarkers for the Non-Invasive Detection of Breast Cancer
Current Opinion in Neurology 2013
Citation only
Impact of brain aging and neurodegeneration on cognition
Frontiers in Aging Neuroscience 2024
Open access · CC-BY
Neural ageing and synaptic plasticity: prioritizing brain health in healthy longevity
Biological Psychiatry Global Open Science 2025
Open access · CC-BY
A Transcriptomic Signature of Depressive Symptoms in Late Life
Adelaide Research & Scholarship (AR&S) (University of Adelaide) 2024
Preprint · OA